Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Lipshultz

Showing results (231-240 of 284) with videos related to

Pageof 29
Sort By:
Journal of the American College of Cardiology|November 25, 2017
Survival Without Cardiac Transplantation Among Children With Dilated CardiomyopathyRakesh K Singh, Charles E Canter, Ling Shi, et al.
JACC. Heart Failure|December 30, 2014
Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expressionCarolyn Y Ho, Neal K Lakdawala, Allison L Cirino, et al.
Circulation|June 21, 2008
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summarySteven K Grinspoon, Carl Grunfeld, Donald P Kotler, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 3, 2023
Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of EchocardiographyLuc Mertens, Gautam Singh, Saro Armenian, et al.
Circulation. Heart Failure|February 15, 2017
Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study GroupPaolo Rusconi, James D Wilkinson, Lynn A Sleeper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxaneElly V Barry, Lynda M Vrooman, Suzanne E Dahlberg, et al.
Pediatric Nephrology (Berlin, Germany)|July 27, 2015
Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy RegistryAhmad Kaddourah, Stuart L Goldstein, Steven E Lipshultz, et al.
The New England Journal of Medicine|July 13, 2004
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemiaSteven E Lipshultz, Nader Rifai, Virginia M Dalton, et al.
Circulation|July 27, 2011
Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registryJorge A Alvarez, E John Orav, James D Wilkinson, et al.
The Journal of Pediatrics|March 25, 2025
Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus AdultsSarah E Messiah, Deepali K Ernest, Folefac D Atem, et al.
Pageof 29

Showing results (231-240 of 284) with videos related to

Sort By:
Pageof 29
Journal of the American College of Cardiology|November 25, 2017
Survival Without Cardiac Transplantation Among Children With Dilated CardiomyopathyRakesh K Singh, Charles E Canter, Ling Shi, et al.
JACC. Heart Failure|December 30, 2014
Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expressionCarolyn Y Ho, Neal K Lakdawala, Allison L Cirino, et al.
Circulation|June 21, 2008
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summarySteven K Grinspoon, Carl Grunfeld, Donald P Kotler, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 3, 2023
Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of EchocardiographyLuc Mertens, Gautam Singh, Saro Armenian, et al.
Circulation. Heart Failure|February 15, 2017
Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study GroupPaolo Rusconi, James D Wilkinson, Lynn A Sleeper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxaneElly V Barry, Lynda M Vrooman, Suzanne E Dahlberg, et al.
Pediatric Nephrology (Berlin, Germany)|July 27, 2015
Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy RegistryAhmad Kaddourah, Stuart L Goldstein, Steven E Lipshultz, et al.
The New England Journal of Medicine|July 13, 2004
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemiaSteven E Lipshultz, Nader Rifai, Virginia M Dalton, et al.
Circulation|July 27, 2011
Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registryJorge A Alvarez, E John Orav, James D Wilkinson, et al.
The Journal of Pediatrics|March 25, 2025
Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus AdultsSarah E Messiah, Deepali K Ernest, Folefac D Atem, et al.
Pageof 29